Target intelligence / Profile preview

Central nervous system gene loci (CNS gene loci)

Target
CNS gene loci
Molecular classification
Other, Genomic DNA, Regulatory element
01

Overview

Central nervous system (CNS) gene loci refer to the specific chromosomal locations containing genes and regulatory elements essential for the development, maintenance, and physiological function of the brain and spinal cord. This term often encompasses conserved non-coding sequences (CNSs), which are segments of the genome that do not encode proteins but are highly preserved across evolutionary history, frequently functioning as cis-regulatory modules like enhancers or silencers (Pennacchio et al., 2006) [1]. In the context of modern genomics and drug discovery, 'CNS gene loci' is a collective term used to describe genomic regions where clusters of risk variants for neurological and psychiatric conditions are identified through genome-wide association studies (GWAS) (Sullivan et al., 2012) [2]. Because the term refers to a vast array of distinct genetic elements rather than a single therapeutic molecule such as a receptor or enzyme, it is not considered a specific drug target. Instead, these loci serve as a foundational map for identifying individual genes or pathways that may be targeted by future precision medicines, antisense oligonucleotides, or gene therapies (Vavouri et al., 2007) [3]. Understanding the variation within these loci is critical for characterizing the genetic architecture of complex diseases like Alzheimer's, schizophrenia, and autism spectrum disorders.

Other names
Conserved non-coding sequencesCNS regulatory elementsNeural genomic lociBrain-expressed gene lociCNS-associated genomic regions
02

Mechanism of action

Not applicable as this term refers to a broad collection of genomic regions rather than a single protein or receptor target.

03

Biological functions

Regulation of gene expressionNeurogenesisSynaptic plasticityNeural developmentCellular differentiation
04

Disease associations

Neurodegenerative diseasePsychiatric disordersNeurodevelopmental disordersCancerMultiple sclerosis
05

Safety considerations

Genetic pleiotropyUnintended disruption of regulatory networksOff-target effects in gene editingEthical considerations in germline modification
06

Biomarkers

Single nucleotide polymorphisms (SNPs)Expression quantitative trait loci (eQTLs)Copy number variants (CNVs)Epigenetic marks (e.g., H3K27ac)

Beyond the preview

Go deeper on Central nervous system gene loci (CNS gene loci).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central nervous system gene loci (CNS gene loci).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call